Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Cytokinetics (CYTK) Restructuring Costs: 2009-2013

Historic Restructuring Costs for Cytokinetics (CYTK) over the last 4 years, with Sep 2013 value amounting to $3.6 million.

  • Cytokinetics' Restructuring Costs rose 179400.00% to $3.6 million in Q3 2013 from the same period last year, while for Sep 2013 it was $7.2 million, marking a year-over-year increase of 99.58%. This contributed to the annual value of -$56,000 for FY2012, which is 104.70% down from last year.
  • Latest data reveals that Cytokinetics reported Restructuring Costs of $3.6 million as of Q3 2013, which was down 0.00% from $3.6 million recorded in Q2 2013.
  • Over the past 5 years, Cytokinetics' Restructuring Costs peaked at $3.9 million during Q1 2011, and registered a low of -$7.7 million during Q4 2010.
  • For the 3-year period, Cytokinetics' Restructuring Costs averaged around $2.2 million, with its median value being $2.5 million (2011).
  • Per our database at Business Quant, Cytokinetics' Restructuring Costs crashed by 101.05% in 2012 and then skyrocketed by 179,400.00% in 2013.
  • Over the past 5 years, Cytokinetics' Restructuring Costs (Quarterly) stood at -$34,457 in 2009, then surged by 11,124.58% to -$7.7 million in 2010, then surged by 147.05% to $3.6 million in 2011, then tumbled by 100.08% to -$2,000 in 2012, then soared by 179,400.00% to $3.6 million in 2013.
  • Its Restructuring Costs was $3.6 million in Q3 2013, compared to $3.6 million in Q2 2013 and -$2,000 in Q3 2012.